The Indian government has officially withdrawn its track-and-trace system for pharmaceutical exports, nearly 14 years after its introduction. The decision comes just before the latest extension, which was set to be valid until February 1, 2025...
Sun Pharmaceutical Industries Limited and Philogen S.p.A. have reported the successful conclusion of patient enrollment in the Phase III FIBROSARC trial for Soft Tissue Sarcoma (STS). All current Fibromun trials are progressing according to their...
Essential Pharma, a global specialty pharmaceutical organization dedicated to providing patients with access to low volume, clinically distinct niche pharmaceutical products in vital therapeutic fields, and Clinigen, the worldwide specialty...
The independent research organization BioMed X has finalized its oncology research initiative in collaboration with Merck, whose data has been obtained by Merck for additional development, possibly resulting in innovative therapeutic methods in...
Dr. Reddy's Laboratories announced that its subsidiary has signed a licensing agreement with Shanghai Henlius Biotech, Inc. to develop and market a cancer drug currently in development. Dr Reddy's Laboratories SA has signed an agreement with the...
Uniphar, a global partner for pharmaceutical and medtech manufacturers, is enhancing its international reach by opening three new facilities, strategically located in major global markets such as Raleigh, Lelystad, and Dublin. Uniphar's recent...
AGC Pharma Chemicals, a leader in pharmaceutical manufacturing with more than 40 years of experience in Contract Development Manufacturing Operations (CDMO) for small molecule APIs located in Barcelona (Spain) and Japan, is enhancing its High...
Jaguar Health, Inc, and Napo Therapeutics revealed that the initial patient suffering from short bowel syndrome with intestinal failure (SBS-IF) has been treated in the independently initiated pediatric proof-of-concept trial (IIT) for crofelemer...
Algiax Pharmaceuticals, a biotech company in the clinical stage that specializes in creating innovative therapies for chronic neuropathic pain, revealed promising topline results from its phase 2a clinical trial assessing AP-325 for neuropathic...
Sigachi Industries Limited, a prominent entity in the pharmaceutical sector, is setting up a research and development center in Hyderabad, unifying its essential API Innovation and analytical initiatives in one location. This strategic plan...
, CDSCO.jpg)
